tiprankstipranks
Natera Inc. (NTRA)
NASDAQ:NTRA
US Market
Want to see NTRA full AI Analyst Report?

Natera (NTRA) Blogger Opinions & Sentiment

1,227 Followers

Blogger Sentiment

Bullish: 70.00%
Sector Average
Bullish
NTRA Blogger sentiment is based on 3 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
66% SeekingAlpha
34% GuruFocus
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Natera: A Growing Biotech, After Recent FDA Approval And Q1 Revenue Results
SeekingAlpha
Natera (NTRA) Reports Strong Q4 2025 Growth and Positive Outlook
GuruFocus
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of NTRA?
Seeking Alpha’s Robert J. Lake has a Neutral Sentiment.
    What do Motley Fool contributors think of NTRA?
    Currently there's no blogger sentiment for NTRA.
    What Is NTRA’s Blogger Sentiment?
    NTRA’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for NTRA?
      The most recent blogger prediction for NTRA was made by Albert Anthony, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          SPHRFStarpharma Holdings Limited
          PRRUFImmutep Ltd
          PRNAFAlterity Therapeutics
          NURPFNeuren Pharmaceuticals Limited
          CLVLFClinuvel Pharmaceuticals